Corvus Pharmaceuticals, Inc. (CRVS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CRVS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 166 institutions reported holding CRVS, with 70.4 million shares worth $1.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Orbimed Advisors | 7,165,006 | $107M | UNCHANGED |
| BlackRock | 7,138,811 | $107M | INCREASED |
| Vanguard | 4,736,087 | $71M | INCREASED |
| State Street | 4,474,091 | $67M | INCREASED |
| T. Rowe Price | 3,789,126 | $57M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Corvus Pharmaceuticals, Inc. on SentiSense.